Anthony Atala, MD
Dr. Atala is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society; the World Technology Award in Health and Medicine, for achieving significant and lasting progress; the Edison Science/Medical Award for innovation, the R&D Innovator of the Year Award, and the Smithsonian Ingenuity Award for Bioprinting Tissue and Organs. Dr. Atala’s work was listed twice as Time Magazine’s Top 10 medical breakthroughs of the year, and once as one of 5 discoveries that will change the future of organ transplants. He was named by Scientific American as one of the world’s most influential people in biotechnology, by U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, by Life Sciences Intellectual Property Review as one of the top key influencers in the life sciences intellectual property arena, and by Nature Biotechnology as one of the top 10 translational researchers in the world.
Julie Watson, JD
|James Yoo, MD, PhD |
Chief Operations Program Officer
Dr. Yoo is a surgeon and researcher whose interest lies in the clinical translation of tissue engineering and cell-based therapies. His background in cell biology and medicine has facilitated the transfer of numerous cell-based technologies from the bench to the bedside. He has been involved in the engineering of applicable tissues and organs, including blood vessels, heart valves, kidney, cartilage, gone, muscle, bladder and urethra for clinical translation. His extensive experience in cell culture, biomaterials design and surgical techniques have contributed to achieving functional tissues and organs for successful pre-clinical and clinical studies.
Shay Soker, PhD
As an expert in the field of angiogenesis, Soker is studying ways to enhance the vascularization and innervation of bioengineered tissues using growth factors and circulating endothelial progenitor cells in angiogenesis.
Joan Schanck, MPA
Joan’s work is focused on providing high quality educational programming within the field of tissue engineering and regenerative medicine. In her role, she also works to increase awareness of the Institute’s leadership role within the field of biomedicine. Joan's professional background includes more than 20 years of specialized experience in administration, education, research, fund raising, collaborative team building, program development and direct care/services delivery within the university, community and non-profit, public health, and education setting. Throughout her career, she has recognized the importance of education and the need to develop collaborative, multidisciplinary education and research training across formal and informal educational environments.
Genevra Kelly, MPH
Chief Philanthropy Program Officer
Genevra focuses on developing public and private sector collaborative partnerships and resources in support of the Institute’s work. She has an extensive background in higher education, health care, and nonprofit markets. Her areas of expertise include collaborative partnerships, including initiating, designing and establishing news public health focused research and patient care programs; federal grant management including pre and post award processes and grants oversight; nonprofit management; and capital campaign design, constituent relations, marketing, public relations, communications, and strategic planning. She is a graduate of Salem Academy, Davidson College (BS – Biology) and USC (MPH). She can be reached at firstname.lastname@example.org regarding opportunities for collaboration and partnership as well as for information on philanthropic opportunities.
|Bonnie Davis |
Chief Communications Program Officer
Bonnie is a print journalist by education and training before transitioning into public relations, serving three NC public school systems as Public Information Officer. She parlayed those skill sets into media relations and has served on the news teams at Wake Forest Baptist Medical Center and Wake Forest University before joining the Institute. Bonnie provides marketing support for the Institute and its education and philanthropy programs, and oversees all internal and external communications functions which includes newsletters, news releases, science research writing for news releases and media relations to provide print, radio, online and broadcast media outlets the access and information to report on the Institute’s break through science endeavors in regenerative medicine.
|Julie G. Allickson, PhD |
Chief Manufacturing Development Center Officer
Julie has more than 25 years of experience in clinical translation of cellular therapies and regenerative medicine products, including business management and board directorship experience. She has eight years of experience as an executive officer with a publicly traded company building services for cellular banking, including licensure of technology with more than 30 affiliates. She is an experienced scientist who excels at delivering innovation, driving milestones, maintaining sensitivity to financial considerations, building multidisciplinary teams, as well as strategic planning, project management, and regulatory expertise. Dr. Allickson has a history of creating value in clinical development and translation.
|Lynn Stedman, MBA |
Chief Research Administration and Finance Officer
Lynn joined the Institute as its inaugural lead of the Office of Research Administration. She obtained her MBA from the University of Alabama at Birmingham and brings 30-plus years of experience with industry and government contracts, contract manufacturing, financial analysis and business management.